HUE062236T2 - Vérlemezke funkció inhibitorok és eljárás azok alkalmazására - Google Patents
Vérlemezke funkció inhibitorok és eljárás azok alkalmazásáraInfo
- Publication number
- HUE062236T2 HUE062236T2 HUE19722359A HUE19722359A HUE062236T2 HU E062236 T2 HUE062236 T2 HU E062236T2 HU E19722359 A HUE19722359 A HU E19722359A HU E19722359 A HUE19722359 A HU E19722359A HU E062236 T2 HUE062236 T2 HU E062236T2
- Authority
- HU
- Hungary
- Prior art keywords
- inhibitors
- methods
- same
- platelet function
- platelet
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862659024P | 2018-04-17 | 2018-04-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE062236T2 true HUE062236T2 (hu) | 2023-10-28 |
Family
ID=66429584
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE19722359A HUE062236T2 (hu) | 2018-04-17 | 2019-04-17 | Vérlemezke funkció inhibitorok és eljárás azok alkalmazására |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11498905B2 (hu) |
| EP (1) | EP3781558B1 (hu) |
| CN (1) | CN113015725A (hu) |
| CA (1) | CA3134447A1 (hu) |
| DK (1) | DK3781558T3 (hu) |
| ES (1) | ES2942214T3 (hu) |
| HU (1) | HUE062236T2 (hu) |
| PL (1) | PL3781558T3 (hu) |
| WO (1) | WO2019204447A1 (hu) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009143039A2 (en) * | 2008-05-19 | 2009-11-26 | Schering Corporation | Heterocyclic compounds as factor ixa inhibitors |
| TW201319068A (zh) * | 2011-08-05 | 2013-05-16 | 必治妥美雅史谷比公司 | 作為ｘｉａ因子抑制劑之環狀ｐ１接合劑 |
| KR102086934B1 (ko) * | 2015-07-29 | 2020-03-09 | 브리스톨-마이어스 스큅 컴퍼니 | 알킬 또는 시클로알킬 P2' 모이어티를 갖는 인자 XIa 마크로시클릭 억제제 |
| US11111222B2 (en) * | 2016-06-23 | 2021-09-07 | The Regents Of The University Of Michigan | Hydroxyeicosatrienoic acid compounds and their use as therapeutic agents |
-
2019
- 2019-04-17 WO PCT/US2019/027881 patent/WO2019204447A1/en unknown
- 2019-04-17 DK DK19722359.7T patent/DK3781558T3/da active
- 2019-04-17 ES ES19722359T patent/ES2942214T3/es active Active
- 2019-04-17 PL PL19722359.7T patent/PL3781558T3/pl unknown
- 2019-04-17 CN CN201980040718.4A patent/CN113015725A/zh active Pending
- 2019-04-17 EP EP19722359.7A patent/EP3781558B1/en active Active
- 2019-04-17 CA CA3134447A patent/CA3134447A1/en active Pending
- 2019-04-17 HU HUE19722359A patent/HUE062236T2/hu unknown
- 2019-04-17 US US17/047,422 patent/US11498905B2/en active Active
-
2022
- 2022-10-19 US US17/969,519 patent/US20230140210A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3781558B1 (en) | 2023-03-01 |
| DK3781558T3 (da) | 2023-04-03 |
| PL3781558T3 (pl) | 2023-05-02 |
| US11498905B2 (en) | 2022-11-15 |
| ES2942214T3 (es) | 2023-05-30 |
| WO2019204447A1 (en) | 2019-10-24 |
| US20230140210A1 (en) | 2023-05-04 |
| CN113015725A (zh) | 2021-06-22 |
| CA3134447A1 (en) | 2019-10-24 |
| US20210363113A1 (en) | 2021-11-25 |
| EP3781558A1 (en) | 2021-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL290399A (en) | kras g12c inhibitors and methods of using them | |
| IL272512A (en) | KRAS G12C inhibitors and methods of using them | |
| IL287223B1 (en) | kras g12c inhibitors and methods of using them | |
| EP3700527A4 (en) | PAPD5 INHIBITORS AND THEIR METHODS OF USE | |
| HK1259232A1 (zh) | Menin-mll的取代抑制劑及其使用方法 | |
| EP3684361A4 (en) | MENINE-MLL SUBSTITUTE INHIBITORS AND METHODS OF USE | |
| EP3510040A4 (en) | ECTONUCLEOTIDASE INHIBITORS AND METHODS OF USE | |
| IL279475A (en) | Actonucleotidase inhibitors and methods of using them | |
| EP3558998A4 (en) | ECTONUCLEOTIDASE INHIBITORS AND METHODS OF USE | |
| IL277600A (en) | AXLkinase inhibitors and their use | |
| IL283387A (en) | Diarylhydantoin compounds and methods of use thereof | |
| IL274504A (en) | 2ACSS inhibitors and methods of their use | |
| EP3621615A4 (en) | APOPTOSIS 1 SIGNAL REGULATION KINASE INHIBITORS AND THEIR METHODS OF USE | |
| IL282350A (en) | Bernani-RGMC inhibitors and their use | |
| EP3846808A4 (en) | PAPD5 INHIBITORS AND METHODS OF USE THEREOF | |
| IL283782A (en) | Analosomes and methods of use | |
| IL286485A (en) | pi4-kinase inhibitors and methods of using them | |
| GB2589398B (en) | Compounds and methods of use | |
| HUE062236T2 (hu) | Vérlemezke funkció inhibitorok és eljárás azok alkalmazására | |
| EP3576745A4 (en) | NGLY1 INHIBITORS AND THEIR METHODS OF USE | |
| EP3849663C0 (en) | PYRIMIDINYL-HETEROARYLOXY-NAPHTHYL COMPOUNDS AND METHODS OF USE | |
| GB201908573D0 (en) | Compounds and methods of use |